Author: Ojosnegros, Samuel; Beerenwinkel, Niko
Title: Models of RNA virus evolution and their roles in vaccine design Document date: 2010_11_3
ID: 0q928h3b_18
Snippet: Recombinant and peptide-based vaccines. A great variety of vaccine strategies can be catalogued inside this category, most of them experimental. Recombinant vaccines are produced by the expression of a genetic construct that codifies viral peptides [47, 48] , subunits of the virus [49] , or whole viruses with genetic modifications including deletions of key proteins [50, 51] . Other strategies include live viral vectors that carry multiple copies.....
Document: Recombinant and peptide-based vaccines. A great variety of vaccine strategies can be catalogued inside this category, most of them experimental. Recombinant vaccines are produced by the expression of a genetic construct that codifies viral peptides [47, 48] , subunits of the virus [49] , or whole viruses with genetic modifications including deletions of key proteins [50, 51] . Other strategies include live viral vectors that carry multiple copies of heterologous proteins of interest [52, 53] . Many of these strategies have failed, mainly because of the low immunogenic capacity of peptides or subunits, compared with the whole live or inactivated particle. The HBV vaccine is a yeast-derived recombinant vaccine. It contains the hepatitis B surface antigen which is one of the viral envelope proteins. HBV vaccine is the only recombinant vaccine currently approved and in use for humans [49] .
Search related documents:
Co phrase search for related documents- envelope protein and heterologous protein: 1, 2, 3, 4, 5, 6, 7
- envelope protein and key protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- envelope protein and recombinant vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- envelope protein and subunit peptide: 1, 2, 3, 4
- envelope protein and surface antigen: 1, 2, 3, 4, 5, 6, 7, 8, 9
- envelope protein and vaccine strategy: 1, 2, 3, 4, 5, 6, 7, 8
- envelope protein and viral envelope protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- envelope protein and viral peptide: 1, 2, 3, 4, 5, 6, 7
- envelope protein and viral vector: 1, 2, 3
- envelope protein and virus subunit: 1, 2, 3, 4, 5, 6
- genetic modification and recombinant vaccine: 1
- genetic modification and viral vector: 1, 2
- great variety and surface antigen: 1
- HBV vaccine and recombinant vaccine: 1, 2, 3, 4
- HBV vaccine and surface antigen: 1, 2, 3, 4, 5, 6
- HBV vaccine and vaccine strategy: 1
- HBV vaccine and viral envelope protein: 1
Co phrase search for related documents, hyperlinks ordered by date